Trial intelligence / Profile preview

High Dose Baclofen for Alcohol Dependence

NCT01980706Phase 2Completed

Sponsor
University of North Carolina at Chapel Hill
Start
Dec 2013
Primary completion
Oct 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of baclofen in alcohol dependence, sponsored by University of North Carolina at Chapel Hill. Started Dec 2013; status: completed.

02

Drugs

baclofen
03

Conditions

alcohol dependence

Beyond the preview

Go deeper on NCT01980706.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01980706.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call